SynteractHCR is a full-service, international CRO

Since 1987, we have been guiding virtual, emerging, and mid-sized biopharma companies across the spectrum of Phase I – IV clinical studies with support services that address their specific needs.

SynteractHCR is a full-service, international CRO

We are dedicated to bringing new treatments to market, working closely with our clients in a spirit of “Shared Work – Shared Vision.” Since 1987, we have been guiding virtual, emerging, and mid-sized biopharma companies across the spectrum of Phase I – IV clinical studies with support services that address their specific needs. Together, we can bring tomorrow’s treatments to patients who need them, today.

Special Announcements!

thumbnailOur ICH GCP Standard Guideline booklet is here!
Is your company prepared to address new ICH GCP Guidelines to safeguard rights, safety and well-being of trial subjects? E6(R2) is the latest addendum to these quality standards. Download this free booklet for what you need to know about the updated principles, procedures and documents in clinical trials.

Latest News & Events

10/16/2017 - 10/17/2017 : DIA/EFGCP/EMA More...

10/4/2017: SynteractHCR, a leading full-service global contract research organization (CRO), has recently moved to its expansive new facility in Carlsbad, California. More ...

8/10/2017: SynteractHCR Announces New Chief Medical Officer Dr. Frank Santoro More ...

Get In Touch

Global Headquarters:
5909 Sea Otter Place
Carlsbad, CA 92010

  • Phone: +1 760 268 8200
  • Fax: +1 760 929 1419

10/13/2017: Are You Prepared to Address Pediatric Plan Requirements? - Did you know that pediatric plans are a requirement for virtually all new medicines, and not just those that are identified as available for children?
SynteractHCR Blog

Connect With Us

10/16/2017: Dr. Martine Dehlinger-Kremer will be attending and speaking at the DIA/EFGCP/EMA Pediatric Conference on “How To Optimize Children’s Access To Innovative Medicines”. Dr. Dehlinger-Kremer is a member of programme committee & session chair for “How To Optimize Drug Development Up To Approval And Beyond”, Oct 17-18, London, UK. https://lnkd.in/gYftmFJ
SynteractHCR on LinkedIn

Follow Us

10/17/2017: RT @Clin_Trials: The Shifting Perspectives on #Pharmacovigilance in Europe. #clinicaltrials #EMA #EU https://t.co/EHG2alLqhX
SynteractHCR Twitter Feed

x

Contact SynteractHCR

Tell us how to stay in touch with you:


Required(*)
Cancel